Neurology
A Blood Test Can See Risk. Policy Cannot Yet Hold It.
A JAMA study shows that plasma p-tau217 helps predict Alzheimer’s progression in cognitively unimpaired older adults. The science is moving fast. The ethics and policy are not.
Tourette Care May Finally Get a New FDA Test
Dementia Is Not the End of Personhood
Narcolepsy Treatment Starts Targeting the Cause
Optic Neuritis Moves Into the Neuroprotection Race
Huntington’s Gene Therapy Moves Back Toward the FDA Door
Alzheimer’s Research Moves Beyond Amyloid
Cellular Reprogramming Enters Neuro-Ophthalmology
Alzheimer’s Agitation Moves Closer to a Phase 2 Readout
ALS Survival Data Return to the Evidence Debate
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.